CoverMyMeds to Play a Major Role in McKesson’s BioPharma Services Strategy

McKesson recently announced that RelayHealth, McKesson Prescription Automation, CoverMyMeds, and RxCrossroads by McKesson, are coming together as one brand under the CoverMyMeds umbrella.

The unified strategy for RelayHealth McKesson Prescription Automation CoverMyMeds and RxCrossroads by McKesson is intended to create a cohesive experience for customers patients and employees.

The unification also is part of McKesson’s ongoing investment in the CoverMyMeds brand and aligns the capabilities around the patient journey to create a cohesive experience for customers, patients and employees.

McKesson has been focused on building out a connected ecosystem over the last several years in the areas of oncology and biopharma services. In terms of biopharma services, CoverMyMeds’ solutions help patients access therapies quicker and increase adherence on those therapies longer.

This value proposition to McKesson’s manufacturing partners is reflected by the over 500 brands the company supports, covering nearly every therapeutic area. McKesson’s priority continues to be growth, and the use of capital continues to be focused on supporting organic growth of its biopharma services strategies, followed by retaining flexibility for acquisitions to accelerate these strategies.

The new CoverMyMeds umbrella includes:

• RelayHealth Pharmacy Solutions manages the nation’s most reliable pharmacy network, powering more than 19 billion pharmacy transactions and connects to more than 50,000 U.S. retail pharmacies.
• McKesson Prescription Automation provides cutting-edge pharmacy dispensing automation, the innovative Sanitas Pharmacy Control System (PCS) software suite, and customized fulfillment systemsdesigned and developed for today’s complex industry.
• CoverMyMeds’ solutions help people get the medicine they need to live healthier lives by seamlessly connecting the healthcare network to improve medication access; thereby increasing speed to therapy and reducing prescription abandonment.
• RxCrossroads’ comprehensive suite of solutions for biopharma and life sciences companies will help clients create, execute and measure the performance of a customized brand strategy across every stage of a product’s lifecycle.

Takeaway: The newly unified businesses are focused on innovating and automating the ways in which biopharma connects with patients, pharmacies and providers with the ultimate goal of providing stronger access, affordability and better adherence outcomes